Skip to content
2000
Volume 28, Issue 8
  • ISSN: 0929-8665
  • E-ISSN: 1875-5305

Abstract

Given that conventional therapies are ineffective for COVID-19, obtained exosomes from stem cells have been proposed as a sustainable and effective treatment. Exosomes are subsets with lengths between 30 and 100 nanometers, and they can be secreted by different cells. Exosomes are containing different types of miRNAs, mRNAs, and different proteins. The role of immune system modulation of exosomes of mesenchymal stem cells has been studied and confirmed in more than one study. Exosome miRNAs detect and reduce cytokines that cause cytokine storms such as IL-7, IL-2, IL-6, etc. These miRNAs include miR-21, miR-24, miR-124, miR-145, etc. The risks associated with treatment with exosomes from different cells are relatively small compared to other treatments because transplanted cells do not stimulate the host immune system and also has reduced infection transmission. Due to the ineffectiveness of existing drugs in reducing inflammation and preventing cytokine storms, the use of immune-boosting systems may be suggested as another way to control cytokine storm.

Loading

Article metrics loading...

/content/journals/ppl/10.2174/0929866528666210222150347
2021-08-01
2025-09-01
Loading full text...

Full text loading...

/content/journals/ppl/10.2174/0929866528666210222150347
Loading

  • Article Type:
    Review Article
Keyword(s): COVID-19; cytokine storm; Exosome; immune system; miRNA; SARS-CoV-2
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test